Skip to navigation Skip to main content
Steve Duffy

Steve Duffy

Steve Duffy is the Digital Editor for MPR, part of the Medical Communications Group of Haymarket Media. He holds a BA in Media and Communications from Dundalk Institute of Technology and an MA in Journalism from Griffith College Dublin (both Ireland).

All articles by Steve Duffy

MPR Weekly Dose Podcast

MPR Weekly Dose Podcast #139

By
Publish Date

FDA pulls bebtelovimab EUA; compounding guidance issued in light of the amoxicillin shortage; the first fecal microbiota treatment is approved; a treatment for Alzheimer disease agitation shows promise; and a gene therapy for Duchenne muscular dystrophy is accepted for Priority Review.

MPR Weekly Dose Podcast

MPR Weekly Dose Podcast #137

By
Publish Date

USPSTF recommendations on estrogen and progesterone; semaglutide assessed in obese teenagers; efficacy and safety data released for investigational maternal RSV vaccine; updates to Clozapine REMS; FDA panel votes on investigational CNS/leptomeningeal metastasis treatment.

MPR Weekly Dose Podcast

MPR Weekly Dose Podcast #136

By
Publish Date

Approvals for relapsed or refractory multiple myeloma, non-radiographic axial spondyloarthritis, and unresectable hepatocellular carcinoma; advisory committee takes vote on potential treatment for anemia of chronic kidney disease; and an oral formulation of pulmonary arterial hypertension treatment.

MPR Weekly Dose Podcast

MPR Weekly Dose Podcast #135

By
Publish Date

FDA Panel votes on the potential removal from the market of Makena; results from an apixaban trial of patients with atrial fibrillation and valvular heart disease; reports of serious ocular complications with monkeypox infection; the novavax vaccine becomes the latest authorized COVID-19 booster; and treatments for nephropathy and ALS have their review period extended.

MPR Weekly Dose Podcast

MPR Weekly Dose Podcast #134

By
Publish Date

Bivalent COVID-19 booster vaccines for children; wearable device to help treat fluid overload in adults with chronic heart failure; real-world data insights into molnupiravir efficacy; vaccine for the third trimester of pregnancy to prevent pertussis; and an FDA update on apomorphine infusion in Parkinson disease.